This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Leukemia & lymphoma · 2005 · senior author
Latest funding
- $50,000
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
CIHR · 2015 · Principal investigator
1 publications.
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Song KW, Mollee PN, Hogge DE, Gupta V, Barnett MJ, Forrest DL, Lavoie JC, Nevill TJ, Nantel SH, Shepherd JD, Smith CA, Sutherland HJ, Toze CL, Crump M, Keating A
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
Principal investigators: Schultz, Kirk R; Tinckam, Kathryn J; Bar-Or, Amit; Keating, Armand; Levings, Megan K
Keywords: Biomarkers; Blood And Marrow Transplantation; Economic Impact Of Health Care; First In Human Clinical Trials; Immune Tolerance; Long Term Outcomes; Multiple Sclerosis; Patient Engagement; Solid Organ Transplantation; Type 1 Diabetes Mellitus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.